CytoSorbents
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, CytoSorbents sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
CytoSorbents: 5 sponsored US clinical trials, none currently recruiting.
CytoSorbents sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. The most-studied condition in this pipeline is Elective Cardiac Surgery, with 1 trials.
Upper-quartile sponsor footprint
CytoSorbents sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)
NCT05093504
Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)
NCT04976530
Registry of CytoSorb Therapy in COVID-19 ICU Patients
NCT04391920
CytoSorb® Reduction of FREee Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery
NCT03384875
CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery
NCT02566525
Therapeutic Areas
How the CytoSorbents archive is shaped
5 indexed studies, none listed as recruiting (0% open); 3 completed (60%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Elective Cardiac Surgery (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
CytoSorbents: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
CytoSorbents sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this CytoSorbents page
5 registered trials is a research-attention snapshot, not an endorsement of CytoSorbents or any single study.
- None of CytoSorbents's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Elective Cardiac Surgery is the condition CytoSorbents studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Elective Cardiac Surgery trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
CytoSorbents pipeline card: 5 registered trials from official public datasets.Report a data error.